Location: Home> Products> Star Products
Click to return to the list
Common name: Doxorubicin Hydrochloride Liposomal Injection
English name: Doxorubicin Hydrochloride Liposome Injection
Approval number: National Drug Standard H20113320 / H20163178
Specification: 10ml: 20mg / 5ml: 10mg
Indications: This product can be used as a first-line systemic chemotherapy drug, or as a second-line chemotherapy drug for patients with progressive AIDS-KS, or for patients who cannot tolerate the combination of two or more of the following drugs: Bleomycin and doxorubicin (or other anthracycline antibiotics). The guidelines are recommended for the treatment of ovarian cancer, lymphoma, multiple myeloma, breast cancer, uterine tumors, and bone and soft tissue sarcomas.